Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C LaFon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Vaccine|January 9, 2020
Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individualsSarah Sterrett, Binghao J Peng, Robert L Burton, et al.
Nature Immunology|January 5, 2024
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adultsSathyabaarathi Ravichandran, Fernando Erra-Diaz, Onur E Karakaslar, et al.
JAMA Network Open|May 21, 2024
β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial InfarctionDavid C LaFon, Erika S Helgeson, Sarah Lindberg, et al.
The European Respiratory Journal|November 28, 2019
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGeneDavid C LaFon, Surya P Bhatt, Wassim W Labaki, et al.
Clinical Immunology (Orlando, Fla.)|April 8, 2023
Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICSDavid C LaFon, Han Woo, Neal Fedarko, et al.
Chest|May 23, 2020
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysisFernando Sergio Leitao Filho, Andre Mattman, Robert Schellenberg, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Vaccine|January 9, 2020
Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individualsSarah Sterrett, Binghao J Peng, Robert L Burton, et al.
Nature Immunology|January 5, 2024
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adultsSathyabaarathi Ravichandran, Fernando Erra-Diaz, Onur E Karakaslar, et al.
JAMA Network Open|May 21, 2024
β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial InfarctionDavid C LaFon, Erika S Helgeson, Sarah Lindberg, et al.
The European Respiratory Journal|November 28, 2019
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGeneDavid C LaFon, Surya P Bhatt, Wassim W Labaki, et al.
Clinical Immunology (Orlando, Fla.)|April 8, 2023
Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICSDavid C LaFon, Han Woo, Neal Fedarko, et al.
Chest|May 23, 2020
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysisFernando Sergio Leitao Filho, Andre Mattman, Robert Schellenberg, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Pageof 2